These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19924834)

  • 1. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
    Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
    J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
    Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
    J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
    Qu LJ; Ding YQ; Liang L
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Trefoil Factor 3 as a Protein Biomarker for the Diagnosis of Colorectal Cancer.
    Li Q; Wang K; Su C; Fang J
    Technol Cancer Res Treat; 2017 Aug; 16(4):440-445. PubMed ID: 27760866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of colorectal cancer glyco-secretome identifies laminin β-1 (LAMB1) as a potential serological biomarker for colorectal cancer.
    Lin Q; Lim HS; Lin HL; Tan HT; Lim TK; Cheong WK; Cheah PY; Tang CL; Chow PK; Chung MC
    Proteomics; 2015 Nov; 15(22):3905-20. PubMed ID: 26359947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
    Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
    Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring changes of serum protein markers in metastatic colorectal carcinoma model].
    Li ZG; Zhao L; Liu L; Ding YQ
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):48-52. PubMed ID: 17374239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.
    Lin PC; Yang YF; Tyan YC; Hsiao ES; Chu PC; Lee CT; Lee JC; Chen YM; Liao PC
    PLoS One; 2016; 11(7):e0158844. PubMed ID: 27383761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
    Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
    J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.
    Zhao L; Liu L; Wang S; Zhang YF; Yu L; Ding YQ
    J Cancer Res Clin Oncol; 2007 Oct; 133(10):771-82. PubMed ID: 17503081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence.
    Toiyama Y; Tanaka K; Kitajima T; Shimura T; Kawamura M; Kawamoto A; Okugawa Y; Saigusa S; Hiro J; Inoue Y; Mohri Y; Goel A; Kusunoki M
    Clin Cancer Res; 2014 Dec; 20(23):6175-86. PubMed ID: 25294915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry.
    Katayama M; Nakano H; Ishiuchi A; Wu W; Oshima R; Sakurai J; Nishikawa H; Yamaguchi S; Otsubo T
    Surg Today; 2006; 36(12):1085-93. PubMed ID: 17123137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct serum assay for cell-free bmi-1 mRNA and its potential diagnostic and prognostic value for colorectal cancer.
    Zhang X; Yang X; Zhang Y; Liu X; Zheng G; Yang Y; Wang L; Du L; Wang C
    Clin Cancer Res; 2015 Mar; 21(5):1225-33. PubMed ID: 25547677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes.
    Nakurte I; Jekabsons K; Rembergs R; Zandberga E; Abols A; Linē A; Muceniece R
    Anticancer Res; 2018 Nov; 38(11):6133-6138. PubMed ID: 30396929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.
    Meding S; Balluff B; Elsner M; Schöne C; Rauser S; Nitsche U; Maak M; Schäfer A; Hauck SM; Ueffing M; Langer R; Höfler H; Friess H; Rosenberg R; Walch A
    J Pathol; 2012 Dec; 228(4):459-70. PubMed ID: 22430872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
    Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
    Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
    Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
    J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.